Bailard’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-68,100
Closed -$121K 794
2023
Q4
$121K Buy
+68,100
New +$121K ﹤0.01% 679